Thermo Fisher Scientific Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
UPDATE: Thermo Fisher Scientific (TMO) Tops Q1 EPS by 15c, Revenues Beat
April 22, 2020 6:02 AM EDT(Updated - April 22, 2020 6:03 AM EDT)
Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $2.94, $0.13 better than the analyst estimate of $2.79. Revenue for the quarter came in at $6.23 billion versus the consensus estimate of $6.17 billion.
First Quarter 2020 Highlights
First quarter revenue increased 2% to $6.23 billion.First quarter GAAP diluted earnings per share (EPS) decreased 2% to $1.97.First quarter adjusted EPS increased 5% to $2.94.Announced agreement to acquire QIAGEN N.V. for $11.5 billion, expanding our specialty diagnostics portfolio with attractive molecular diagnostics capabilities and enhancing our life sciences offering with innovative sample preparation... More